Santarus (SNTS) to Present at Piper Jaffray 21st Annual Health Care Conference

Santarus, Inc. (NASDAQ: SNTS), a specialty biopharmaceutical company, announced that Gerald T. Proehl, president and chief executive officer, will make a presentation at the Piper Jaffray 21st Annual Health Care Conference on Wednesday, December 2, 2009, at 12:30 p.m. Eastern time (9:30 a.m. Pacific time) at The New York Palace Hotel in New York City.
An audio webcast of the presentation will be available during the event at www.santarus.com and will be archived and available on the Web site for 14 days.

Santarus, Inc.( SNTS) is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by gastroenterologists and other physicians. Santarus is also developing two late-stage lower GI product candidates, budesonide MMX® and rifamycin SV MMX®, for the U.S. market.